PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Health Decision Science, Harvard University, Boston, MA, USA. Electronic address: zward@hsph.harvard.edu.\', \'Research Department of Epidemiology and Public Health, University College London, London, UK.\', \'Department of Hematology Oncology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.\', \'National Health Fund (FONASA), Santiago, Chile.\', \'Department of Public Health, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.\', \'Department of Global Health and Population, Harvard University, Boston, MA, USA; Harvard TH Chan School of Public Health, and Department of Global Health and Social Medicine, Harvard Medical School, Harvard University, Boston, MA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1470-2045(21)00426-510.1016/S1470-2045(21)00426-5
?:doi
?:hasPublicationType
?:journal
  • The Lancet. Oncology
is ?:pmid of
?:pmid
?:pmid
  • 34487693
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all